US20090259140A1 - Apparatus and methods for acoustically or mechanically stimulating a cochlea and intracochlear recording of mechanically or acoustically evoked auditory potentials in the cochlea - Google Patents
Apparatus and methods for acoustically or mechanically stimulating a cochlea and intracochlear recording of mechanically or acoustically evoked auditory potentials in the cochlea Download PDFInfo
- Publication number
- US20090259140A1 US20090259140A1 US12/422,926 US42292609A US2009259140A1 US 20090259140 A1 US20090259140 A1 US 20090259140A1 US 42292609 A US42292609 A US 42292609A US 2009259140 A1 US2009259140 A1 US 2009259140A1
- Authority
- US
- United States
- Prior art keywords
- cochlea
- acoustic
- electrophysiologic
- electrophysiologic response
- cochlear
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000003477 cochlea Anatomy 0.000 title claims abstract description 132
- 230000000763 evoking effect Effects 0.000 title claims abstract description 54
- 238000000034 method Methods 0.000 title claims abstract description 51
- 230000004936 stimulating effect Effects 0.000 title claims description 11
- 230000004044 response Effects 0.000 claims abstract description 122
- 230000000638 stimulation Effects 0.000 claims abstract description 55
- 238000005259 measurement Methods 0.000 claims abstract description 45
- 208000016354 hearing loss disease Diseases 0.000 claims abstract description 44
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 18
- 239000007943 implant Substances 0.000 claims description 52
- 230000013707 sensory perception of sound Effects 0.000 claims description 50
- 238000003780 insertion Methods 0.000 claims description 19
- 230000037431 insertion Effects 0.000 claims description 19
- 210000000860 cochlear nerve Anatomy 0.000 claims description 18
- 238000002513 implantation Methods 0.000 claims description 17
- 210000000988 bone and bone Anatomy 0.000 claims description 12
- 210000003027 ear inner Anatomy 0.000 claims description 11
- 238000012377 drug delivery Methods 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 5
- 208000014674 injury Diseases 0.000 claims description 5
- 230000008733 trauma Effects 0.000 claims description 5
- 230000036982 action potential Effects 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 238000012077 behavioral audiometry Methods 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 238000001415 gene therapy Methods 0.000 claims description 3
- 230000003542 behavioural effect Effects 0.000 claims description 2
- 238000009168 stem cell therapy Methods 0.000 claims description 2
- 238000009580 stem-cell therapy Methods 0.000 claims description 2
- 230000002596 correlated effect Effects 0.000 claims 1
- 238000002405 diagnostic procedure Methods 0.000 abstract description 2
- 210000002768 hair cell Anatomy 0.000 description 86
- 230000004913 activation Effects 0.000 description 17
- 210000000613 ear canal Anatomy 0.000 description 16
- 230000001537 neural effect Effects 0.000 description 12
- 230000008904 neural response Effects 0.000 description 12
- 230000005788 Cochlea function Effects 0.000 description 11
- 238000011282 treatment Methods 0.000 description 11
- 206010011878 Deafness Diseases 0.000 description 10
- 230000003915 cell function Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 231100000888 hearing loss Toxicity 0.000 description 10
- 230000010370 hearing loss Effects 0.000 description 10
- 210000001323 spiral ganglion Anatomy 0.000 description 9
- 238000001356 surgical procedure Methods 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 230000006727 cell loss Effects 0.000 description 7
- 238000005070 sampling Methods 0.000 description 7
- 210000001079 scala tympani Anatomy 0.000 description 7
- 208000009966 Sensorineural Hearing Loss Diseases 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 210000005036 nerve Anatomy 0.000 description 6
- 238000004321 preservation Methods 0.000 description 6
- 206010011891 Deafness neurosensory Diseases 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 231100000879 sensorineural hearing loss Toxicity 0.000 description 5
- 208000023573 sensorineural hearing loss disease Diseases 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000003491 array Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000013507 mapping Methods 0.000 description 4
- 210000003454 tympanic membrane Anatomy 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000020411 cell activation Effects 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 239000004020 conductor Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 210000000959 ear middle Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000028161 membrane depolarization Effects 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 230000002123 temporal effect Effects 0.000 description 3
- 230000001960 triggered effect Effects 0.000 description 3
- 238000012935 Averaging Methods 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000003984 auditory pathway Anatomy 0.000 description 2
- 210000003030 auditory receptor cell Anatomy 0.000 description 2
- 210000000133 brain stem Anatomy 0.000 description 2
- 230000009087 cell motility Effects 0.000 description 2
- 239000003246 corticosteroid Substances 0.000 description 2
- 229960001334 corticosteroids Drugs 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 210000004126 nerve fiber Anatomy 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 210000001050 stape Anatomy 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- YDHOAQXHVQTASS-UHFFFAOYSA-N 3-amino-n-hydroxypropanamide Chemical compound NCCC(=O)NO YDHOAQXHVQTASS-UHFFFAOYSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 241000878128 Malleus Species 0.000 description 1
- 208000030854 Vestibulocochlear Nerve disease Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 230000009925 apoptotic mechanism Effects 0.000 description 1
- 208000002982 auditory neuropathy Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000000262 cochlear duct Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002999 depolarising effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 210000001785 incus Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000013383 initial experiment Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000002331 malleus Anatomy 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000005055 memory storage Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000008035 nerve activity Effects 0.000 description 1
- 210000000118 neural pathway Anatomy 0.000 description 1
- 230000010004 neural pathway Effects 0.000 description 1
- 230000007514 neuronal growth Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- ZLIBICFPKPWGIZ-UHFFFAOYSA-N pyrimethanil Chemical compound CC1=CC(C)=NC(NC=2C=CC=CC=2)=N1 ZLIBICFPKPWGIZ-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- 210000001154 skull base Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000005236 sound signal Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 208000023088 sudden sensorineural hearing loss Diseases 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0048—Detecting, measuring or recording by applying mechanical forces or stimuli
- A61B5/0051—Detecting, measuring or recording by applying mechanical forces or stimuli by applying vibrations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/12—Audiometering
- A61B5/121—Audiometering evaluating hearing capacity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/12—Audiometering
- A61B5/121—Audiometering evaluating hearing capacity
- A61B5/123—Audiometering evaluating hearing capacity subjective methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/12—Audiometering
- A61B5/121—Audiometering evaluating hearing capacity
- A61B5/125—Audiometering evaluating hearing capacity objective methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/369—Electroencephalography [EEG]
- A61B5/377—Electroencephalography [EEG] using evoked responses
- A61B5/38—Acoustic or auditory stimuli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/686—Permanently implanted devices, e.g. pacemakers, other stimulators, biochips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6867—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive specially adapted to be attached or implanted in a specific body part
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
- A61N1/0541—Cochlear electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
- A61M2005/1726—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure the body parameters being measured at, or proximate to, the infusion site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0662—Ears
Definitions
- the presently disclosed subject matter relates to an apparatus for mechanical or acoustic stimulation of the cochlea and measurement of an electrophysiologic response to the mechanical or acoustic stimulation and methods of using the apparatus.
- the presently disclosed subject matter relates to an apparatus having an acoustic or mechanical stimulator for generating acoustically or mechanically evoked electrophysiologic responses in the cochlea and an intracochlear measuring device for recording these responses.
- the presently disclosed subject matter further relates to methods of using the apparatus for evaluating hearing impairment and selecting treatment therapies based on the evaluation using the apparatus disclosed herein.
- Hearing in humans requires conduction of the acoustic signal to the inner ear by way of the external auditory canal, tympanic membrane, and ossicles (i.e., malleus, incus, and stapes). Vibration of the stapes bone (i.e., the 3 rd ossicle) within the oval window of the inner ear sets the inner ear fluids in motion thereby inducing activation of hair cells in the cochlea. Hair cell activation results in cochlear nerve fiber depolarization, ultimately leading to central auditory pathway stimulation within the brainstem.
- ossicles i.e., malleus, incus, and stapes.
- Hearing impairments can be classified as either conductive, resulting from pathologies of the external auditory canal, tympanic membrane, and/or ossicles, or sensorineural.
- Sensorineural hearing losses most commonly result from either hair cell loss within the cochlea or as a consequence cochlear nerve disorders.
- the most common factor for SNHL is hair cell loss.
- hair cell losses can occur throughout the cochlea, the most commonly involved regions are the high frequency (high pitch) regions.
- the cochlea has a tonotopical arrangement, which means that tones close to each other in terms of frequency are received by hair cells in topologically neighboring regions of the cochlea ( FIG. 1 ).
- hair cells in the basal region (base) of the cochlea are activated by high frequency sound
- hair cells in the apical region (apex) of the cochlea are activated by low frequency sound.
- hair cell losses occur most commonly in the basal regions of the cochlea, resulting in high frequency hearing impairment.
- Effective hearing impairment treatment necessitates accurate determination of the cause and/or extent of hearing impairment. For example, to provide an effective and specific treatment for a hearing impairment, it is desirable to determine whether hearing impairment is conductive or sensorineural, and if sensorineural, whether it is a result of hair cell loss or neural disorder. Further, if hearing impairment results from loss of hair cell function, it would be desirable to determine the topological extent of hair cell loss to better tailor a treatment specifically for the hearing deficit. Present technologies for measuring hearing impairment are unable to provide a complete and accurate determination of the cause and/or extent of hearing impairment, particularly with regard to assessment of hair cell function.
- OAEs evoked-otoacoustic emissions
- ABR auditory brainstem response
- behavioral audiograms For almost 20 years, otoacoustic emissions (measure of hair cell motion and resultant sound from the hair cell motion) have been relied upon to provide information about the functional status of the inner ear. Due to the specificity of OAEs for outer hair cells, this technique can be sensitive in the early diagnosis of hair cell pathology. However, beyond about 40 decibels (dB) of hearing loss, OAEs are lost, making further assessment impossible. Moreover, the recording mechanism relies on several factors outside the inner ear, making OAE testing both indirect and inaccurate during times of pathology.
- dB decibels
- ABR hair cell function
- ECG electrocochleography
- the cochlear microphonic potential is believed to be mainly a result of basal cochlear hair cells with a negligible fraction of apical hair cell contribution.
- this technique does not allow for measurement of apical hair cell function.
- an apparatus for acoustic and/or mechanical stimulation and electrophysiologic response measurement of a cochlea can comprise an acoustic or mechanical stimulator and an electrophysiologic response-measuring device.
- An acoustic stimulator generates an acoustic signal and can be positioned within an external auditory canal of a subject.
- the acoustic stimulator is positioned outside the external auditory canal, such as utilizing a free-field speaker or a headphone speaker.
- mechanical energy can be used to stimulate the cochlea.
- a mechanical or vibrotactile stimulator can drive the ossicular chain or the other parts of the middle ear to provide cochlear stimulation.
- Another possible mode of stimulation would be to directly drive the round or oval window via a mechanical stimulator.
- Yet another possible method for stimulating the cochlea would be to apply mechanical energy via a bone vibration device.
- the measuring device may be positioned inside the cochlea and measures an electrophysiologic response by the cochlea (e.g., resulting from hair cells within the cochlea) or the auditory neurons of the spiral ganglion to the acoustic or mechanical signal.
- an electrophysiologic response by the cochlea e.g., resulting from hair cells within the cochlea
- the auditory neurons of the spiral ganglion to the acoustic or mechanical signal.
- the acoustic stimulator can comprise a generator for generating the acoustic signal and a speaker that transmits the acoustic signal.
- the acoustic signal can be sound waves at a predetermined frequency range of from about 20 Hertz to about 20,000 Hertz.
- the acoustic signal generates an electrophysiologic response that is measured by the measuring device.
- a mechanical stimulator can be used to stimulate the cochlea in this same frequency range.
- the electrophysiologic response can be an acoustically or mechanically evoked electrical potential generated by activation of hair cells and/or spiral ganglion cells.
- the response-measuring device measures the electrophysiologic events with at least one sampling window of from about 0.2 milliseconds to about 100 milliseconds.
- the measuring device comprises at least one electrode for measuring the electrophysiologic responses and can include an array of electrodes.
- the measuring device is positioned in close proximity to the hair cells within the cochlea and can in some embodiments be positioned within the scala tympani of the cochlea.
- the acoustic or mechanical stimulator and the measuring device can in some embodiments be in communication by way of a trigger.
- the trigger synchronizes activation of the acoustic or mechanical stimulator to generate the acoustic or mechanical signal and activation of the measuring device to measure the electrophysiologic responses in a temporary synchronized manner.
- the trigger may be a signal generated by the measuring device to activate the mechanical or acoustic stimulator.
- the trigger may be a signal generated by the mechanical or acoustic stimulator to activate the measuring device.
- the presently disclosed subject matter further provides method of measuring cochlear responses to an acoustic or mechanical signal.
- the method comprises acoustically or mechanically stimulating a cochlea with an acoustic or mechanical signal and measuring an electrophysiologic response by the cochlea to the acoustic or mechanical signal.
- the method comprises generating the acoustic or mechanical signal with an acoustic or mechanical stimulator disclosed herein.
- An electrophysiologic response-measuring device measures the electrophysiologic responses from within the cochlea and thus is believed to provide a more direct measure of cochlear function than OAE and ABR testing, for example, which rely on measuring devices located outside of the cochlea.
- a method of selecting a hearing impairment treatment therapy is provided.
- a cochlea is acoustically or mechanically stimulated with an acoustic or mechanical signal.
- An electrophysiologic response by the cochlea e.g., a hair cell or neural response
- a hearing impairment in the cochlea is determined based on the measured electrophysiologic response.
- a therapy based on the determined hearing impairment is then selected. Determining the hearing impairment can include mapping tonotopic functionality of the cochlea (i.e., correlating physical locations of functioning hair cells in the cochlea to acoustically-detected frequencies and impairments thereof).
- the therapy is selected from the group consisting of a cochlear implant, a drug, a gene therapy, a stem cell therapy, and combinations thereof. Further, in some embodiments, the therapy is a cochlear implant implemented as a component of an electric-acoustic stimulation therapy.
- FIG. 1 is a schematic drawing showing tonotopic arrangement of the cochlea. High frequencies are located basally and low frequencies are located apically.
- FIG. 2 is a schematic drawing showing an embodiment of the device of the presently disclosed subject matter for acoustic cochlear stimulation and intracochlear recording of acoustically or mechanically evoked potentials.
- a speaker is placed within the external auditory canal to deliver an acoustic stimulus and a triggering mechanism synchronizes the auditory output with the electrophysiologic response measuring device, shown as a recording electrode array in this embodiment.
- FIG. 3 is a schematic diagram illustrating a mechanical stimulator suitable for mechanically evoking auditory potentials according to an embodiment of the subject matter described herein.
- FIG. 4 is a schematic cross-sectional drawing of a cochlea showing positioning of an electrophysiologic response measuring device for measuring acoustically or mechanically evoked cochlear potentials.
- the measuring device comprises an electrode array positioned within the scala tympani of the cochlea for measuring acoustically or mechanically evoked potentials derived from activation of hair cells or neural elements, which are proximate to the electrode array.
- FIG. 5 is a schematic drawing showing an embodiment of electric acoustic stimulation (EAS) of the auditory system.
- EAS electric acoustic stimulation
- the basal section of the cochlea (high frequencies) can be stimulated via a cochlear implant and if needed the apical section of the cochlea (low frequencies) can be stimulated via a conventional hearing aid (or without hearing aid if residual low frequency hearing is satisfactory).
- FIG. 6 is a flow chart illustrating interactions between a trigger, an acoustic or mechanical stimulator, and an electrophysiologic response-measuring device in one embodiment of the subject matter disclosed herein.
- FIG. 7 is a graph showing measurements of responses achieved after acoustic stimulation of the cochlea at different frequencies (1 kHz and 2 kHz).
- the presently disclosed subject matter provides apparatus for acoustic or mechanical stimulation of a cochlea and intracochlear recording of acoustically or mechanically evoked electrophysiologic responses in the cochlea for use in diagnostic and/or therapeutic procedures related to sensorineural hearing impairment.
- “Hearing impairment”, as used herein, can refer to a measurable reduction in hearing capabilities (over a broad and/or narrow range of frequencies) as compared to a comparable normal subject not suffering from measurable hearing impairment.
- the presently disclosed subject matter allows for measuring hearing impairment in a subject by direct measurement of acoustically or mechanically evoked electrophysiologic responses (e.g., hair cell or neural activation, including for example auditory neurons of the spiral ganglion) in the subject, which can provide data with improved signal-to-noise ratio (i.e., greater intensity of the signal and/or lower intensity of noise) and therefore a more accurate determination of sensorineural hearing impairment with tonotopic specificity by direct measure of hair cell activity and/or neural responses from the auditory system.
- acoustically or mechanically evoked electrophysiologic responses e.g., hair cell or neural activation, including for example auditory neurons of the spiral ganglion
- signal-to-noise ratio i.e., greater intensity of the signal and/or lower intensity of noise
- a measuring device as disclosed herein within the inner ear, hair cell activity or activity within the spiral ganglion in the form of electrical potentials can be measured directly adjacent to the cells of origin, rather than indirectly as provided by present techniques.
- a direct hair-cell evaluation can provide a much more detailed evaluation of the functional status of the inner ear.
- the summating potential of the spiral ganglion (CAP) can be recorded with a much better signal-to-noise ratio.
- the presently disclosed subject matter provides for the direct recording of acoustically or mechanically evoked auditory potentials with a measuring device, such as for example one or more electrodes, placed within the cochlea.
- a measuring device such as for example one or more electrodes
- the terms are meant to include not only placement of the device within the interior of the cochlea, but also within close proximity to the cochlea (e.g., in contact with the exterior of the cochlea), so long as the device is positioned sufficiently proximate the cochlea to detect an acoustically or mechanically evoked electrophysiologic response, as opposed to a far-field recording site distant from the cochlea.
- cochlear implants introduce an electrode into the cochlea, they are designed to directly stimulate auditory neural pathways and are not configured to record acoustically or mechanically evoked auditory potentials.
- the electrical stimulation function can be disabled, and measurement electrodes can be triggered to measure auditory potentials in response to mechanical or acoustic stimulation.
- Certain cochlear implants can include a feature for recording neural elements in the distal auditory nerve excited by electrical stimulation through the cochlear implant to verify correct device placement, but not to measure hair cell potentials.
- cochlear implants are used to stimulate auditory nerves electrically and, and in some instances record resulting electrical auditory potentials.
- recording systems are termed: NRT (neural response telemetry), NRI (neural response imaging), or ART (auditory nerve response telemetry) (Mason, 2004; Battmer et al., 2004; Shallop et al., 1999).
- NRT neural response telemetry
- NRI neural response imaging
- ART auditory nerve response telemetry
- none of these recording systems are designed to record acoustically or mechanically evoked auditory potentials.
- presently-available devices usually measure compound nerve action potentials from the spiral ganglion of the cochlear nerve, and therefore cannot provide data related to hair cell function.
- currently available systems are only
- the presently disclosed subject matter differs significantly from present cochlear implant recording systems in that with the present subject matter, an acoustical or mechanical (rather than an electrical) stimulus is applied and an electrophysiologic response resulting from acoustically or mechanically evoked hair cell or neural activation is directly measured.
- An acoustic or mechanical stimulus will primarily activate (residual) intracochlear hair cells, rather than nerves proximal in the auditory system, as occurs with electrical stimulation by present cochlear implants.
- neural activation is measured as an electrophysiologic response to an acoustic or mechanical stimulus, it can be a surrogate marker of functionally linked hair cell activation. This provides direct information as to the functionality of hair cells and the geographic abundance of functioning hair cells.
- a device of the presently disclosed subject matter for recording acoustically or mechanically evoked potentials can include in some embodiments an intracochlear electrophysiologic response measuring device, such as for example a recording electrode or electrode array, that is coupled to and triggered with (or vice versa) an acoustic stimulator for generating an acoustic signal in the external auditory canal ( FIG. 2 ).
- the acoustic stimulator can comprise an electroacoustic device, which can include for example a generator for generating the acoustic signal and a speaker that transmits the acoustic signal.
- “speaker” can refer to both a generator and speaker as a single device.
- the speaker can be positioned within the external auditory canal, or can be outside the auditory canal, such as for example a headphone or free-field speaker.
- the acoustic stimulator can generate as an acoustic signal, a sound wave, for example.
- the acoustic signal may have a predetermined frequency or frequency range that changes to facilitate measurement of cochlear electrophysiologic responses at different frequencies ( FIG. 1 ).
- the acoustic stimulator can generate over a time period a range of different frequencies to provide a spectrum of cochlear function.
- the frequency range of the acoustic signal can be from about 20 Hz to about 20,000 Hz.
- Atraumatic insertion and positioning of such a recording system into the cochlea can be accomplished utilizing hearing preservation surgical techniques, as would be understood by one of skill in the art.
- the same frequencies or frequency ranges may be generated by a mechanical stimulator to evaluate cochlear function at different frequencies.
- apparatus 20 includes a speaker 22 as part of an acoustic stimulator and a recording electrode array 24 as an electrophysiologic response measuring device.
- electrode array 24 comprises an elongate and flexible structure that curls to match the contours of the region of the cochlea in which it is inserted.
- the outer wall of cochlea CO is shown in a semi-transparent manner so that electrode 24 is visible.
- Speaker 22 can (but not necessarily) be positioned in the external auditory canal AC and generates an acoustic signal 26 directed toward the cochlea CO.
- Acoustic signal 26 is transmitted from external auditory canal AC by way of the tympanic membrane TM and ossicles OS to cochlea CO.
- acoustic signal 26 Upon transmission into cochlea CO, acoustic signal 26 is transformed into mechanical energy that can activate hair cells to generate an electrical potential, which is transmitted to the brain via nerve fibers. More specifically, hair cell activation results in cellular depolarization. Such activation secondarily results in cochlear nerve depolarization that is transmitted to the brain.
- Such depolarizing responses in both the cochlear hair cells and nerves can be generated by acoustic stimulation and can be measured.
- electrode array 24 records the generation of an electrical potential by the hair cells or nerves.
- the recorded signal can be transmitted, for example wirelessly using radio waves, to a user for analysis.
- An example of a device suitable for use as speaker 22 is the model number 019-746802, available from Viasys, Conshohocken, Pa., USA. Speaker 22 may be driven by an ABR device to generate acoustic stimuli.
- Examples of devices suitable for use as electrode 24 are Pulsar Ci100, (MED-EL, Innsbruck, Austria), Nucleus Freedom (Cochlear Corporation, Lane Cove, NSW, Australia), or 90K Hi Resolution cochlear implant system (Advanced Bionics Corp, Sylmar, Calif., USA).
- a mechanical stimulus may be utilized to evoke an auditory potential.
- a system to apply mechanical energy could be a direct drive system of the ossicular chain or the round window. Likewise, the oval window could be directly stimulated.
- An existing system suitable for applying mechanical energy could be the floating mass transducer (FMT) of the Vibrant Soundbridge (MED-EL, Innsbruck, Austria) or similar fully or semi-implantable devices applying mechanical energy to the acoustic system.
- FIG. 3 is a block diagram illustrating the FMT device and a trigger and audio potential recorder to record mechanically stimulated auditory potentials according to an embodiment of the subject matter described herein.
- FMT device 300 is attached to one of the bones in the ossicular chain.
- An audio processor 302 encodes externally generated sound and communicates that sound to a subcutaneous receiver 304 .
- Receiver 304 encodes the sound communicates the encoded sound to FMT device 300 via a conductor 306 .
- FMT device 300 vibrates in response to external stimuli and thus transfers mechanical energy to the bone to which it is attached.
- the device illustrated in FIG. 3 functions as a hearing aid.
- the system illustrated in FIG. 3 can be used in combination with electrode 24 illustrated in FIG. 2 to mechanically evoke auditory potentials and to record those potentials.
- audio processor 302 and/or receiver 304 may be configured to generate encoded audio signals such that FMT device 300 vibrates at predetermined frequencies.
- One of audio processor 302 , receiver 304 , or conductor 306 may be coupled to trigger and auditory potential recorder 308 to trigger the recording of auditory potentials generated by electrode 24 .
- Trigger and auditory potential recorder 308 may be coupled to electrode 24 to record auditory potentials generated in response to mechanical or auditory stimulation.
- Trigger and auditory potential recorder 308 may be implemented in hardware, software, firmware, or any combination thereof.
- trigger and auditory potential recorder 308 may be implemented using a general purpose computing platform, such as a personal computer, with interfaces to the stimulus generation mechanism and to the recording electrode.
- a floating mass transducer to mechanically stimulate an auditory potential.
- another suitable device for use as a mechanical energy applicator could be a bone anchored hearing aid such as the BAHA hearing system (Cochlear Corporation, Lane Cove, NSW, Australia).
- BAHA hearing system Cochlear Corporation, Lane Cove, NSW, Australia.
- a conventional bone conduction hearing aid could be used to apply mechanical energy to the cochlea.
- the electrophysiologic response-measuring device may be positioned within the cochlea so as to allow for measurement of acoustically or mechanically evoked electrophysiologic responses resulting from hair cell stimulation and/or nerve responses.
- the electrophysiologic response-measuring device may be positioned in an intracochlear location or external the cochlea, but in close proximity to the cochlea (e.g., contacting the cochlea). Localized in an intracochlear position, the physiologic response measuring device can be located proximal to hair cells of the cochlea to better directly receive electrophysiologic responses. For example, in one embodiment an electrophysiologic response measuring device, shown in FIG.
- Electrode array 24 can be positioned within the scala tympani 32 of the cochlea CO, which is adjacent the scala media SM (below scala vestibule SV) where hair cells HC reside. Positioning within the scala tympani ST allows for direct measurement of electrical potentials arising from either hair cell HC or neural activation and transmitted initially through hair cells to nerves HCN.
- the electrophysiologic response measuring device can include at least one electrode contact for measuring an acoustically or mechanically evoked electrophysiologic response resulting from hair cell stimulation.
- the electrophysiologic response measuring device can include a plurality of electrodes arranged in an array. This arrangement allows for measurement of hair cells across a portion or even the entire cochlea. Further, data from the individual electrodes in the array can be tracked, which provides information as to tonotopic functionality of the hair cells within the cochlea.
- the electrode array can extend the entire length of the cochlea and in other embodiments, the electrode array extends along a portion of the cochlea, such as for example only along the basal portion of the cochlea to measure high-frequency hair cell stimulation (e.g., about 1,500-20,000 Hz) or only along the apical portion of the cochlea to measure low-frequency hair cell stimulation (e.g., about 200-600 Hz) ( FIG. 1 ).
- FIG. 5 shows an intracochlear electrode array 24 implanted within the cochlea CO and extending partially, but not completely, within the cochlea CO for measurement of electrophysiologic responses resulting from hair cell stimulation.
- an electrode array adapted from a cochlear implant (with or without the other components of the cochlear implant) for stimulation of cochlear nerves can be utilized.
- exemplary cochlear implants are described in detail in U.S. Pat. Nos. 4,400,590; 4,532,930; 4,592,359; 4,947,844; 5,776,172; 6,067,474; and 6,980,864, the disclosure of each of which is incorporated by reference herein in its entirety.
- cochlear implant systems include an implanted receiver/stimulator connected to an implanted electrode array.
- the receiver/stimulator can deliver current to particular electrodes in the array that stimulate determined frequencies of the cochlear nerves in response to signals from an external acoustic receiver.
- the implanted receiver/stimulator can further include a transmitter for telemetering electrode voltage, measured during stimulation, to an external receiver for monitoring and analysis as an indicator of proper operation of the implanted stimulator.
- Cochlear implant electrode arrays having capacity to also transmit measured voltages can be adapted for use with the presently disclosed subject matter. Rather than measure voltage applied by the stimulator, the electrode array can be utilized to measure and transmit acoustically or mechanically evoked electrophysiologic responses originating from activation of hair cells or neural elements, as disclosed herein.
- the electrophysiologic response measuring device can include an electrode array derived from a cochlear implant (with or without other components of the implant) to measure acoustically or mechanically evoked electrical potentials from activated hair cells.
- a cochlear implant used for electrical stimulation and response measurement can be modified to disable or omit the electrical stimulation function, to trigger the generation of auditory potentials, and to record the acoustically or mechanically evoked auditory potentials within a time window or windows that have a predetermined temporal relationship with the acoustic or mechanical stimulation.
- a cochlear implant used for electrical stimulation and response measurement was modified to generate a trigger signal.
- the trigger signal was coupled to an external acoustic stimulator to trigger generation of an acoustic stimulus.
- the cochlear implant was then used to record auditory potentials generated within the cochlea in response to the acoustic stimulus. Exemplary data recorded in response to the stimulus will be described in detail below.
- the apparatus for acoustic or mechanical stimulation and electrophysiologic response measurement further comprises a trigger for facilitating communication between the acoustic or mechanical stimulator and the electrophysiologic response measuring device.
- a trigger for facilitating communication between the acoustic or mechanical stimulator and the electrophysiologic response measuring device.
- an apparatus 50 for acoustic stimulation and electrophysiologic response measurement includes an acoustic stimulator 52 , such as for example a stimulator comprising speaker 22 , in communication with an electrophysiologic response measuring device 56 , such as for example a measuring device comprising electrode array 24 , through a trigger 54 .
- trigger 54 may be a signal generated by acoustic or mechanical stimulator 52 such that activation of acoustic stimulator 52 to generate an acoustic signal for stimulation of a cochlea activates measuring device 56 .
- Measuring device 56 and/or an associated computer that stores responses to mechanical or acoustic stimuli may be timed to record evoked auditory potentials for a desired time period after acoustic or mechanical stimulator 52 generates the acoustic or mechanical signal.
- electrophysiologic response measuring device 56 and acoustic or mechanical stimulator 52 may be controlled by a computer (not shown), and trigger 54 may be a software algorithm that activates electrophysiologic response measuring device 54 after activating acoustic stimulator 52 .
- trigger 54 may be a signal generated by neural response measuring device 56 that instructs acoustic or mechanical stimulator 52 to generate an acoustic or mechanical signal.
- neural response measuring device 56 and/or a computer associated with neural response measuring device 56 may record evoked auditory potentials for a predetermined time window related to the length of acoustic or mechanical stimulation
- trigger 54 facilitates a recording by measuring device 56 following each acoustic signal at a certain time interval (e.g., a sampling window). Single recordings or continuous recordings after repetitive acoustic stimuli can be performed, if desired.
- trigger 54 can be activated in response to either activation of acoustic or mechanical stimulator 52 to generate an acoustic or mechanical signal, or in response to activation of measuring device 56 to begin measuring a sampling window of electrophysiologic responses.
- trigger 54 after detecting activation of measuring device 56 , activates acoustic or mechanical stimulator 52 to generate an acoustic or mechanical signal.
- the sampling window begins recording a set time period prior to activation of acoustic or mechanical stimulator 52 .
- Software for management of trigger 54 can, in some embodiments, be modified from existing cochlear implant software. Additional modifications of the software, if desired, can include an acoustic or mechanical stimulus generator (e.g., pure-tones, clicks, as well as other forms of acoustic waveforms or corresponding mechanical waveforms) and a module that can move the recording window (usually a relatively time-constrained interval of from about 0.2 to about 100 milliseconds. (ms)) in relation to the acoustic signal, which can in some embodiments facilitate activation of the trigger.
- an acoustic or mechanical stimulus generator e.g., pure-tones, clicks, as well as other forms of acoustic waveforms or corresponding mechanical waveforms
- a module that can move the recording window usually a relatively time-constrained interval of from about 0.2 to about 100 milliseconds. (ms) in relation to the acoustic signal, which can in some embodiments facilitate activation of the trigger.
- Another embodiment for software instructions for recording intracochlear potentials includes instructions for increasing the duration of the recording time period, such as for example to provide a sampling window of less than about 100 ms, such as from about 0.2 ms to about 100 ms, from about 2 ms to about 10 ms, or from about 4 ms to about 5 ms.
- constraints may exist as to how much data can be stored in the internal memory and to the sampling rate of measuring device 56 (temporal resolution), for which one of skill in the art would be familiar and take into consideration when balancing sampling window size, timing and resolution needs.
- the presently disclosed subject matter further provides methods of utilizing an apparatus as disclosed herein for generating an acoustic or mechanical signal as an acoustic or mechanical stimulus for a cochlea of a subject and measuring an electrophysiologic response by the cochlea to the acoustic or mechanical stimulus.
- the apparatus can include an acoustic or mechanical stimulator for generating the acoustic signal and an electrophysiologic response measuring device for measuring the acoustically or mechanically evoked electrophysiologic response to the acoustic stimulus.
- the stimulator is an acoustic stimulator comprising a sound applicator including at least one speaker for generating sound waves.
- the acoustic stimulator can be positioned within the external auditory canal, as shown in FIG. 2 , to direct the acoustic stimulus toward the cochlea to be measured. Additionally, the acoustic stimulator can in some embodiments be located outside the external auditory ear canal, to generate an acoustic stimulus externally, such as by way of free-field acoustics or headphones, for example.
- the acoustic stimulus can stimulate functioning hair cells in the cochlea to generate an electrical potential transmitted through auditory nerves (e.g., nerves of the spiral ganglion).
- the cochlea can be stimulated by application of mechanical energy to the acoustic system. Specifically, mechanical energy can be applied to the ossicular chain or any other parts of the auditory system. Mechanical energy can be applied via a bone conductor or other suitable mechanical device such as an active middle ear implant or a bone anchored hearing aid.
- the electrophysiologic response-measuring device can be positioned within the cochlea (see FIG. 4 ) to facilitate direct measure of the acoustically or mechanically evoked electrophysiologic response (e.g., hair cell or neural potentials) and provide an assessment of hair cell function and viable hair cell distribution, which are indicative of hearing function. Determination of the type and degree of hearing impairment using an apparatus as disclosed herein can further facilitate selection of a hearing impairment treatment therapy. In some embodiments, a hearing impairment is determined by measuring an electrophysiologic response by the cochlea to an acoustic or mechanical signal. Determination of the hearing impairment then facilitates selection of an appropriate and tailored treatment for the hearing impairment, which can provide the benefits of a more effective treatment and one that preserves residual hearing while treating the hearing impairment, as described in further detail below.
- a hearing impairment is determined by measuring an electrophysiologic response by the cochlea to an acoustic or mechanical signal. Determination of the hearing impairment then facilitates selection of an appropriate and tailored treatment for the hearing
- an intracochlear recording system as disclosed herein that can measure acoustically or mechanically evoked electrophysiologic responses include, for example, real-time monitoring for hearing preservation attempts during cochlear implant surgery. Additional applications include, for example, diagnostic assessments during other surgeries of the inner ear (skull base surgery (McElveen et al., 1991), etc.) or even tailoring the approach to a variety of cochlear-specific therapies. Directing therapies to specific anatomic regions and assessing the ongoing results of therapies (Light & Silverstein, 2004; Schwaber, 2002) can also be achieved utilizing the presently disclosed apparatus and methods. Further, from a research perspective, the presently disclosed subject matter provides multiple opportunities for better understanding the validity of a variety of commonly held assumptions in the hearing sciences.
- the apparatus disclosed herein allows for direct assessment of functionality of hair cell populations and neural elements from within the cochlea, which can facilitate mapping of tonotopic functionality in a subject.
- the apparatus can include an electrophysiologic response measuring device with an intracochlear electrode array or a single electrode.
- the array or the single electrode can be inserted into the cochlea through the external auditory canal and then through the round window under either general or local anesthesia.
- manual or servo assisted techniques can be used.
- the posterior external auditory canal wall and the basal cochlear turn encompass almost a 90° angle. Since the basal cochlear turn does not follow the direction of the bony posterior canal wall, a tungsten-rod for stabilizing and deflecting the extracochlear part of the insertion electrode can be used.
- the insertion tool can thus act like a deflection instrument to guide the electrode atraumatically into the scala tympani of the cochlea.
- an acoustic stimulator including a small speaker system can be placed in the auditory canal to provide acoustic stimulation.
- any method for the application of mechanical energy as outlined above can be used.
- Recordings of electrophysiologic responses can be made from a variety of locations within the cochlea either using multiple electrodes on a single array or a single electrode that is advanced to a variety of different anatomical locations.
- Waveforms can if desired be extracted through averaging, although very beneficial signal-to-noise ratios already result from the intracochlear placement of the recording electrode(s) (i.e. the recording electrode is very close to the origin of the biological signal).
- intracochlear devices e.g., cochlear implants
- drugs e.g., small molecule pharmaceuticals
- gene therapies e.g., gene therapies
- stem cells see e.g., Tang et al., 2006
- cochlear implants stimulate the cochlear (e.g., auditory, acoustic) nerve in regions of the cochlea where hair cell populations have been lost. Since many cases of SNHL involve high frequency losses, partial implantation of an intracochlear electrode in the basal (i.e., first or lower) portion of the cochlea can electrically stimulate high frequency nerve fibers. If hair cell function in the low frequency regions is preserved in a subject treated for high frequency hearing impairment, conventional amplification (e.g., hearing aids) can be used in these regions.
- conventional amplification e.g., hearing aids
- EAS electric-acoustic stimulation
- Gantz & Turner hybrid cochlear implantation
- the presently disclosed apparatus for measuring acoustically or mechanically evoked auditory potentials can be used as a tool to measure residual cochlear function during cochlear implantation.
- the information generated by apparatus disclosed herein can be used to provide a real-time direct measure of the feasibility of bi-modal stimulation during surgery and determine the precise depth of electrode implantation needed for subjects with residual functioning hair cell populations.
- EAS relies on the ability of the implanting surgeon to preserve residual cochlear function.
- the surgeon was left to undertake the surgery and assume the hearing had been preserved. Following recovery, hearing would be assessed weeks later. If hearing is preserved, bi-modal stimulation is undertaken. When hearing has been lost, auditory stimulation can only be provided by the implant. Since the electrodes used for bi-modal stimulation are significantly shorter than those used for conventional full cochlear implantation, revision implantation with a longer electrode array must be considered (Battmer et al., 2004).
- measuring cochlear function during cochlear implantation can assist the surgeon in determining whether EAS is feasible while still in the operating room. For example, if complete loss or significant attenuation of acoustically or mechanically evoked auditory potentials is observed during surgery, hearing preservation would be considered unlikely and full electrode insertions with a standard, cochlear implant electrode would be prescribed.
- tonotopic mapping using the present apparatus and methods indicates residual hearing, then an appropriately-sized and positioned cochlear stimulating electrode can be implanted and an EAS plan implemented for the subject.
- EAS relies on the preservation of hearing during surgery (Gstoettner et al., 2004; Kiefer et al., 2005).
- the basic concept of EAS is that those areas of the cochlea with residual hair cell populations can be used for acoustic hearing (with or without amplification), whereas electrical stimulation can cover areas without functioning hair cells.
- the ideal EAS electrode array insertion would be that situation where the distal (i.e. deepest, apical cochlear sections) electrode would be advanced just up to the point where hair cell populations are present. This would thereby avoid either a gap or an overlap between the two stimulation paradigms (i.e. acoustic and electric).
- Standard cochlear implant electrode arrays also vary in length but may be as long as 31.5 mm.
- these proposed insertion depths represent relatively arbitrary numbers with little basis for choice, except for the notion that deeper implantations cause an increase in intracochlear trauma and thus increase the likelihood of further hearing loss due to damage to existing residual hair cell populations.
- the presently disclosed subject matter provides for real-time, intraoperative monitoring of cochlear function during electrode insertion.
- insertion ceases, and residual hair cell populations are preserved.
- the subject would have a 7 mm electrode array (or slightly shorter) implanted.
- a longer array e.g., up to 24 mm in length
- a customized electrode array designed to the particular needs of the individual subject can be used, rather than an electrode of arbitrary standard length, which can provide optimal hearing assistance needed while avoiding damage to residual hearing still available to the subject.
- the presently disclosed subject matter provides apparatus and methods for acoustic or mechanical stimulation of a cochlea and for recording acoustically or mechanically evoked auditory activity from hair cells and auditory neural structures using one or more electrodes positioned within the cochlea.
- Some cochlear implants provide an intracochlear recording device, however, these are not designed to measure acoustically evoked electrophysiologic responses.
- Development of such a recording device either by modifying currently available cochlear implants, or by providing a diagnostic intracochlear device can provide a broad functional assessment of the peripheral (cochlear and spiral ganglion) auditory system.
- the following experiments set forth in the Examples can be carried out to establish the presently disclosed stimulation/recording paradigm in a diagnostic intracochlear recording device, which can include as one component all or portions of a modified cochlear implant.
- modifications to establish recording of acoustically evoked auditory potentials can be achieved.
- the modifications can provide inclusion of a triggering mechanism between the acoustic or mechanical stimulation and the intracochlear electrophysiologic measurements.
- the modification can further include a function to turn-off the electrical stimulation usually present in cochlear implants used to measure electrically evoked auditory potentials.
- the acoustic stimulus can be positioned in temporal relationship to the intracochlear recording procedure without recording electrically evoked potentials, such that only acoustically or mechanically evoked potential is measured.
- Initial experiments can be performed to establish the trigger for the acoustic or mechanical output and the recording signals. An aim of these experiments is to determine the correct timing for the recording after the acoustic stimulus has been triggered.
- normative data can be established in subjects who have received a cochlear implant and show some residual hearing on the implanted ear. Some hearing remnants can be recorded in about 50% of subjects who have been implanted with electrode arrays. Since cochlear microphonics can sometimes be recorded in profoundly deaf individuals, potentials can be recordable even in subjects who have lost residual hearing due to cochlear implantation (or who did not show residual hearing prior to implantation).
- Subjects with auditory neuropathy can be measured to determine acoustically or mechanically evoked potentials from hair cells in isolation, thus providing a clean signal. These subjects have no synchronized neural response that may artifactually obscure the early hair cell and neural responses. Subjects with increasing residual hearing can then be tested, after a baseline waveform of hair cell neural responses is determined in the neuropathy subjects. Inverting click or mechanical stimulus polarity in both groups can be useful for determining hair cell response versus early neural responses.
- each cochlear implant recipient can undergo testing both during and after cochlear implantation at different intervals.
- correlations between conventional behavioral audiometry and acoustically or mechanically evoked intracochlear recordings can be sought. This way, information about the range of acoustically or mechanically evoked auditory potentials in ears with various degrees of residual hearing can be sought. For instance, if hearing is present after implantation at a given frequency, measurements can be made with the device described herein to identify those intracochlear regions that have electrophysiologic responses present in response to the same acoustic signal. Correlating these behavioral responses with the acoustically generated electrophysiologic measures generated with the device described herein allows validation or even rediscription of the tonotopical arrangement of the cochlea.
- the present Example relates to the development of an intracochlear recording device for diagnostic purposes alone or coupled with a therapeutic treatment, such as a drug-delivery system, as disclosed herein.
- a therapeutic treatment such as a drug-delivery system
- the basis for such a system is to measure electrical activity of hair cells and auditory neural structures in particular segments of the cochlea and specifically treat intracochlear locations pharmacologically (e.g., with neural growth factors, apoptotic inhibitors, corticosteroids).
- the present Example discloses clinical data showing measurement of acoustically evoked potentials (EP) measured intracochlearly that follow an acoustic tonal stimulus.
- EP acoustically evoked potentials
- FIG. 7 shows results from one electrode obtained from acoustically-stimulating hair cells and measuring electrophysiologic response using an electrode array inserted in the cochlea of a human subject.
- the electrode utilized for deriving the data of FIG. 7 sits in the basal and middle cochlear turns; the corresponding frequency is assumed to be about 1000 Hz.
- Trace 60 is the measured electrical response to a 2-kHz tone acoustic stimulus used, which is plotted on the graph as waveform 62 for comparison.
- Traces 64 and 66 are measured electrical responses to a 1-kHz acoustic stimulus, which is plotted on the graph as waveform 68 for comparison.
- Trace 66 was taken 1.7 ms ‘after’ trace 64 (i.e., a delay was introduced before the measurement for those data), and the phase of the response shifted by 0.7 ms, as predicted.
- the data traces shown in FIG. 6 were processed for clarity of signal; however, the unprocessed signals also showed a clear response to the acoustic signal.
- an electrophysiologic response measurement device 56 can be a modified cochlear implant or a dedicated diagnostic device that is designed to be inserted in the cochlea for diagnostic purposes and then withdrawn.
- the electrophysiologic measurement device may be used to measure cochlear trauma cause by insertion of the device into the cochlea. For example, if the device is being inserted in the cochlea, acoustically evoked auditory potentials can be recorded at different times and levels of insertion. If the response measurement for the same cochlear region worsens from one time to another, the degradation in response may indicate cochlear trauma caused by impingement of the device on a cochlear structure.
- the implant or diagnostic device may be withdrawn to reduce the impingement on the cochlea or other factor that contributed to the response degradation.
- the procedure of measuring acoustically evoked auditory potentials during insertion can be used to distinguish between reversible and irreversible hearing loss. For example, a loss caused by impingement during insertion may be reversible by withdrawal of the diagnostic or implantation electrode. Similarly, an evoked auditory potential that is constant for different times during insertion may indicate an irreversible hearing loss.
- an electrophysiologic response measurement device including a dedicated diagnostic device or a modified cochlear implant, may further be used for delivering diagnostic electrical stimulation to the cochlea.
- the electrophysiologic response measurement device can be used to deliver a diagnostic electrical stimulation to such regions and record the resulting evoked auditory potential.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Audiology, Speech & Language Pathology (AREA)
- Otolaryngology (AREA)
- Acoustics & Sound (AREA)
- Multimedia (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Prostheses (AREA)
- Electrotherapy Devices (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/422,926 US20090259140A1 (en) | 2006-10-13 | 2009-04-13 | Apparatus and methods for acoustically or mechanically stimulating a cochlea and intracochlear recording of mechanically or acoustically evoked auditory potentials in the cochlea |
| US13/949,975 US9072468B2 (en) | 2006-10-13 | 2013-07-24 | Apparatus and methods for acoustically or mechanically stimulating a cochlea and intracochlear recording of mechanically or acoustically evoked auditory potentials in the cochlea |
| US14/726,252 US9380962B2 (en) | 2006-10-13 | 2015-05-29 | Apparatus and methods for acoustically or mechanically stimulating a cochlea and intracochlear recording of mechanically or acoustically evoked auditory potentials in the cochlea |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85140006P | 2006-10-13 | 2006-10-13 | |
| PCT/US2007/017614 WO2008048383A1 (fr) | 2006-10-13 | 2007-08-08 | Appareil et procédés de stimulation acoustique ou mécanique d'une cochlée et d'enregistrement intracochlaire de potentiels auditifs évoqués mécaniquement ou acoustiquement dans la cochlée |
| US12/422,926 US20090259140A1 (en) | 2006-10-13 | 2009-04-13 | Apparatus and methods for acoustically or mechanically stimulating a cochlea and intracochlear recording of mechanically or acoustically evoked auditory potentials in the cochlea |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2007/017614 Continuation-In-Part WO2008048383A1 (fr) | 2006-10-13 | 2007-08-08 | Appareil et procédés de stimulation acoustique ou mécanique d'une cochlée et d'enregistrement intracochlaire de potentiels auditifs évoqués mécaniquement ou acoustiquement dans la cochlée |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US13/949,975 Continuation US9072468B2 (en) | 2006-10-13 | 2013-07-24 | Apparatus and methods for acoustically or mechanically stimulating a cochlea and intracochlear recording of mechanically or acoustically evoked auditory potentials in the cochlea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20090259140A1 true US20090259140A1 (en) | 2009-10-15 |
Family
ID=39314322
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US12/422,926 Abandoned US20090259140A1 (en) | 2006-10-13 | 2009-04-13 | Apparatus and methods for acoustically or mechanically stimulating a cochlea and intracochlear recording of mechanically or acoustically evoked auditory potentials in the cochlea |
| US13/949,975 Active US9072468B2 (en) | 2006-10-13 | 2013-07-24 | Apparatus and methods for acoustically or mechanically stimulating a cochlea and intracochlear recording of mechanically or acoustically evoked auditory potentials in the cochlea |
| US14/726,252 Active US9380962B2 (en) | 2006-10-13 | 2015-05-29 | Apparatus and methods for acoustically or mechanically stimulating a cochlea and intracochlear recording of mechanically or acoustically evoked auditory potentials in the cochlea |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US13/949,975 Active US9072468B2 (en) | 2006-10-13 | 2013-07-24 | Apparatus and methods for acoustically or mechanically stimulating a cochlea and intracochlear recording of mechanically or acoustically evoked auditory potentials in the cochlea |
| US14/726,252 Active US9380962B2 (en) | 2006-10-13 | 2015-05-29 | Apparatus and methods for acoustically or mechanically stimulating a cochlea and intracochlear recording of mechanically or acoustically evoked auditory potentials in the cochlea |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US20090259140A1 (fr) |
| EP (1) | EP2076174A4 (fr) |
| AU (1) | AU2007313412A1 (fr) |
| CA (1) | CA2673126A1 (fr) |
| WO (1) | WO2008048383A1 (fr) |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090254149A1 (en) * | 2008-04-03 | 2009-10-08 | Med-El Elektromedizinische Geraete Gmbh | Synchronized Diagnostic Measurement for Cochlear Implants |
| US20100114288A1 (en) * | 2008-10-31 | 2010-05-06 | Advanced Bionics, Llc | Cochlear electrode insertion |
| US20110098785A1 (en) * | 2009-10-23 | 2011-04-28 | Advanced Bionics, Llc | Fully Implantable Cochlear Implant Systems Including Optional External Components and Methods for Using the Same |
| US20110144529A1 (en) * | 2008-07-24 | 2011-06-16 | Maria Cecilia Perez-Abalo | Method and Apparatus for the Objective Detection of Auditive Disorders |
| US20110275953A1 (en) * | 2010-05-05 | 2011-11-10 | Med-El Elektromedizinische Geraete Gmbh | Hearing Treatment In Patients With Questionable Cochlear Nerve Functionality |
| CN102908150A (zh) * | 2012-09-27 | 2013-02-06 | 清华大学 | 一种复合神经动作电位调谐曲线校准及检测系统 |
| US20140236043A1 (en) * | 2011-09-21 | 2014-08-21 | Jacoti Bvba | Method and Device for Conducting a Pure Tone Audiometry Screening |
| US9072468B2 (en) | 2006-10-13 | 2015-07-07 | The University Of North Carolina At Chapel Hill | Apparatus and methods for acoustically or mechanically stimulating a cochlea and intracochlear recording of mechanically or acoustically evoked auditory potentials in the cochlea |
| US9211403B2 (en) | 2009-10-30 | 2015-12-15 | Advanced Bionics, Llc | Steerable stylet |
| US9440072B2 (en) | 2012-03-22 | 2016-09-13 | Advanced Bionics Ag | Methods and systems for fitting an electro-acoustic stimulation system to a patient |
| WO2018037312A1 (fr) * | 2016-08-24 | 2018-03-01 | Cochlear Limited | Surveillance de l'insertion d'un ensemble de stimulation |
| CN108601937A (zh) * | 2016-01-27 | 2018-09-28 | 领先仿生公司 | 在电极导线插入过程期间对耳蜗创伤的术中监测的系统和方法 |
| JP2018153532A (ja) * | 2017-03-21 | 2018-10-04 | カシオ計算機株式会社 | 脳波測定装置、脳波測定方法及び脳波測定プログラム |
| US20200238002A1 (en) * | 2017-10-12 | 2020-07-30 | Cochlear Limited | Clinical-based automated delivery of treatment substances to the inner ear |
| US20210138236A1 (en) * | 2019-11-07 | 2021-05-13 | Oticon Medical A/S | Method for detecting a plurality of health conditions of a cochlea |
| CN112891742A (zh) * | 2015-01-09 | 2021-06-04 | Med-El电气医疗器械有限公司 | 经由传出神经纤维的耳蜗植入器适配 |
| US11090485B2 (en) | 2015-10-13 | 2021-08-17 | Advanced Bionics Ag | Systems and methods for intra-surgical monitoring of evoked responses that occur during an electrode lead insertion procedure |
| CN114748037A (zh) * | 2022-03-14 | 2022-07-15 | 江勇 | 一种人工植入肝脏弹性检测装置 |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110245235A1 (en) * | 2008-10-10 | 2011-10-06 | Hanley Peter J | Systems, Methods, and Devices for Rehabilitation of Auditory System Disorders Using Pharmaceutical Agents and Auditory Devices |
| EP3054847B1 (fr) * | 2013-10-08 | 2018-09-26 | Advanced Bionics AG | Systèmes permettant d'identifier une ou plusieurs régions de mort intracochléaire |
| DK2904972T3 (da) * | 2014-02-05 | 2021-08-16 | Oticon As | Indretning til bestemmelse af dødt cochlear-område |
| CN108883274B (zh) * | 2016-02-29 | 2022-03-18 | 领先仿生公司 | 用于使用诱发的响应来确定行为听力图值的系统和方法 |
| US10413728B2 (en) * | 2016-04-22 | 2019-09-17 | Cochlear Limited | Electrocochleography testing in hearing prostheses |
| EP3244635A1 (fr) * | 2016-05-12 | 2017-11-15 | Oticon Medical A/S | Système d'aide auditive et son procédé de fonctionnement |
| US10292644B2 (en) | 2016-06-21 | 2019-05-21 | Cochlear Limited | Automated inner ear diagnoses |
| US10842531B2 (en) * | 2016-06-22 | 2020-11-24 | Cochlear Limited | Electrode insertion tool with additional functionality |
| US11285314B2 (en) | 2016-08-19 | 2022-03-29 | Cochlear Limited | Advanced electrode array insertion |
| US11071856B2 (en) | 2017-03-24 | 2021-07-27 | Cochlear Limited | Advanced electrode array location evaluation |
| TWI633871B (zh) | 2017-06-22 | 2018-09-01 | 國立清華大學 | 聽力診斷裝置與聽力資訊偵測方法 |
| CN116271537A (zh) * | 2017-08-28 | 2023-06-23 | 领先仿生公司 | 用于检测耳蜗植入患者的耳蜗内的电极引线的阶移位的系统和方法 |
| WO2019102266A1 (fr) | 2017-11-22 | 2019-05-31 | Cochlear Limited | Systèmes et procédés de test d'actionneurs |
| CN111902186B (zh) | 2018-03-20 | 2025-06-13 | 科利耳有限公司 | 身体生理的假体管理 |
| CN117563136A (zh) * | 2018-03-26 | 2024-02-20 | 科利耳有限公司 | 用于耳蜗中的生物标记检测的电气技术 |
| US11471074B2 (en) * | 2018-07-30 | 2022-10-18 | The University Of Electro-Communications | Middle ear sound transmission characteristics evaluation system, middle ear sound transmission characteristics evaluation method, and measuring probe |
| CN115919297B (zh) * | 2018-07-30 | 2025-08-05 | 国立大学法人电气通信大学 | 计测探头 |
| WO2021007412A1 (fr) * | 2019-07-10 | 2021-01-14 | Ohio State Innovation Foundation | Dispositifs prothétiques auditifs utilisant des potentiels auditifs précoces comme microphone et procédés associés |
| WO2025010075A1 (fr) * | 2023-07-06 | 2025-01-09 | Advanced Bionics Llc | Systèmes et procédés d'identification d'une réponse évoquée mesurée par l'intermédiaire d'un implant cochléaire |
Citations (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4400590A (en) * | 1980-12-22 | 1983-08-23 | The Regents Of The University Of California | Apparatus for multichannel cochlear implant hearing aid system |
| US4532930A (en) * | 1983-04-11 | 1985-08-06 | Commonwealth Of Australia, Dept. Of Science & Technology | Cochlear implant system for an auditory prosthesis |
| US4592359A (en) * | 1985-04-02 | 1986-06-03 | The Board Of Trustees Of The Leland Stanford Junior University | Multi-channel implantable neural stimulator |
| US4947844A (en) * | 1984-09-07 | 1990-08-14 | The University Of Melbourne | Receiver/stimulator for hearing prosthesis |
| US5012814A (en) * | 1989-11-09 | 1991-05-07 | Instromedix, Inc. | Implantable-defibrillator pulse detection-triggered ECG monitoring method and apparatus |
| US5776172A (en) * | 1989-09-22 | 1998-07-07 | Alfred E. Mann Foundation For Scientific Research | Multichannel implantable cochlear stimulator |
| US5776179A (en) * | 1995-10-06 | 1998-07-07 | The University Of Michigan | Method for evaluating inner ear hearing loss |
| US5999856A (en) * | 1997-02-21 | 1999-12-07 | St. Croix Medical, Inc. | Implantable hearing assistance system with calibration and auditory response testing |
| US6067474A (en) * | 1997-08-01 | 2000-05-23 | Advanced Bionics Corporation | Implantable device with improved battery recharging and powering configuration |
| US6231604B1 (en) * | 1998-02-26 | 2001-05-15 | Med-El Elektromedizinische Gerate Ges.M.B.H | Apparatus and method for combined acoustic mechanical and electrical auditory stimulation |
| US20020004516A1 (en) * | 1998-12-15 | 2002-01-10 | Jean-Marie Stutzmann | Use of riluzole in the treating acoustic traumas |
| US6640121B1 (en) * | 1999-08-10 | 2003-10-28 | The University Of Miami | Otic microprobe for neuro-cochlear monitoring |
| US20050131272A1 (en) * | 2003-12-11 | 2005-06-16 | Bernd Waldmann | Electrophysiological measurement method and system for positioning an implantable, hearing instrument transducer |
| US6916291B2 (en) * | 2001-02-07 | 2005-07-12 | East Carolina University | Systems, methods and products for diagnostic hearing assessments distributed via the use of a computer network |
| US20050261748A1 (en) * | 2004-05-10 | 2005-11-24 | Cochlear Limited | Cochlear implant fitting |
| US6980864B2 (en) * | 2000-03-31 | 2005-12-27 | Advanced Bionics Corporation | High contact count, sub-miniature, full implantable cochlear prosthesis |
| US20070015727A1 (en) * | 2002-09-06 | 2007-01-18 | Jean-Luc Puel | Delivery of modulators of glutamate-mediated neurotransmission to the inner ear |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19618961B4 (de) * | 1996-05-10 | 2004-09-16 | Phonak Ag | Gerät zur elektromechanischen Stimulation und Prüfung des Gehörs |
| WO2002082982A1 (fr) | 2001-04-18 | 2002-10-24 | Cochlear Limited | Procede et appareil de mesure de reponses neuronales evoquees |
| CA2673126A1 (fr) | 2006-10-13 | 2008-04-24 | The University Of North Carolina At Chapel Hill | Appareil et procedes de stimulation acoustique ou mecanique d'une cochlee et d'enregistrement intracochlaire de potentiels auditifs evoques mecaniquement ou acoustiquement dans lacochlee |
-
2007
- 2007-08-08 CA CA002673126A patent/CA2673126A1/fr not_active Abandoned
- 2007-08-08 EP EP07836613A patent/EP2076174A4/fr not_active Withdrawn
- 2007-08-08 WO PCT/US2007/017614 patent/WO2008048383A1/fr not_active Ceased
- 2007-08-08 AU AU2007313412A patent/AU2007313412A1/en not_active Abandoned
-
2009
- 2009-04-13 US US12/422,926 patent/US20090259140A1/en not_active Abandoned
-
2013
- 2013-07-24 US US13/949,975 patent/US9072468B2/en active Active
-
2015
- 2015-05-29 US US14/726,252 patent/US9380962B2/en active Active
Patent Citations (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4400590A (en) * | 1980-12-22 | 1983-08-23 | The Regents Of The University Of California | Apparatus for multichannel cochlear implant hearing aid system |
| US4532930A (en) * | 1983-04-11 | 1985-08-06 | Commonwealth Of Australia, Dept. Of Science & Technology | Cochlear implant system for an auditory prosthesis |
| US4947844A (en) * | 1984-09-07 | 1990-08-14 | The University Of Melbourne | Receiver/stimulator for hearing prosthesis |
| US4592359A (en) * | 1985-04-02 | 1986-06-03 | The Board Of Trustees Of The Leland Stanford Junior University | Multi-channel implantable neural stimulator |
| US5776172A (en) * | 1989-09-22 | 1998-07-07 | Alfred E. Mann Foundation For Scientific Research | Multichannel implantable cochlear stimulator |
| US5012814A (en) * | 1989-11-09 | 1991-05-07 | Instromedix, Inc. | Implantable-defibrillator pulse detection-triggered ECG monitoring method and apparatus |
| US5776179A (en) * | 1995-10-06 | 1998-07-07 | The University Of Michigan | Method for evaluating inner ear hearing loss |
| US5999856A (en) * | 1997-02-21 | 1999-12-07 | St. Croix Medical, Inc. | Implantable hearing assistance system with calibration and auditory response testing |
| US6067474A (en) * | 1997-08-01 | 2000-05-23 | Advanced Bionics Corporation | Implantable device with improved battery recharging and powering configuration |
| US6231604B1 (en) * | 1998-02-26 | 2001-05-15 | Med-El Elektromedizinische Gerate Ges.M.B.H | Apparatus and method for combined acoustic mechanical and electrical auditory stimulation |
| US20020004516A1 (en) * | 1998-12-15 | 2002-01-10 | Jean-Marie Stutzmann | Use of riluzole in the treating acoustic traumas |
| US6640121B1 (en) * | 1999-08-10 | 2003-10-28 | The University Of Miami | Otic microprobe for neuro-cochlear monitoring |
| US6980864B2 (en) * | 2000-03-31 | 2005-12-27 | Advanced Bionics Corporation | High contact count, sub-miniature, full implantable cochlear prosthesis |
| US6916291B2 (en) * | 2001-02-07 | 2005-07-12 | East Carolina University | Systems, methods and products for diagnostic hearing assessments distributed via the use of a computer network |
| US20070015727A1 (en) * | 2002-09-06 | 2007-01-18 | Jean-Luc Puel | Delivery of modulators of glutamate-mediated neurotransmission to the inner ear |
| US20050131272A1 (en) * | 2003-12-11 | 2005-06-16 | Bernd Waldmann | Electrophysiological measurement method and system for positioning an implantable, hearing instrument transducer |
| US20050261748A1 (en) * | 2004-05-10 | 2005-11-24 | Cochlear Limited | Cochlear implant fitting |
Cited By (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9380962B2 (en) | 2006-10-13 | 2016-07-05 | The University Of North Carolina At Chapel Hill | Apparatus and methods for acoustically or mechanically stimulating a cochlea and intracochlear recording of mechanically or acoustically evoked auditory potentials in the cochlea |
| US9072468B2 (en) | 2006-10-13 | 2015-07-07 | The University Of North Carolina At Chapel Hill | Apparatus and methods for acoustically or mechanically stimulating a cochlea and intracochlear recording of mechanically or acoustically evoked auditory potentials in the cochlea |
| US8170678B2 (en) | 2008-04-03 | 2012-05-01 | Med-El Elektromedizinische Geraete Gmbh | Synchronized diagnostic measurement for cochlear implants |
| US20090254149A1 (en) * | 2008-04-03 | 2009-10-08 | Med-El Elektromedizinische Geraete Gmbh | Synchronized Diagnostic Measurement for Cochlear Implants |
| US9345419B2 (en) * | 2008-07-24 | 2016-05-24 | Centro De Neurosciencias De Cuba | Method and apparatus for the objective detection of auditive disorders |
| US20110144529A1 (en) * | 2008-07-24 | 2011-06-16 | Maria Cecilia Perez-Abalo | Method and Apparatus for the Objective Detection of Auditive Disorders |
| US20100114288A1 (en) * | 2008-10-31 | 2010-05-06 | Advanced Bionics, Llc | Cochlear electrode insertion |
| US8594799B2 (en) | 2008-10-31 | 2013-11-26 | Advanced Bionics | Cochlear electrode insertion |
| US20110098785A1 (en) * | 2009-10-23 | 2011-04-28 | Advanced Bionics, Llc | Fully Implantable Cochlear Implant Systems Including Optional External Components and Methods for Using the Same |
| US8706246B2 (en) * | 2009-10-23 | 2014-04-22 | Advanced Bionics | Fully implantable cochlear implant systems including optional external components and methods for using the same |
| US9211403B2 (en) | 2009-10-30 | 2015-12-15 | Advanced Bionics, Llc | Steerable stylet |
| US20110275953A1 (en) * | 2010-05-05 | 2011-11-10 | Med-El Elektromedizinische Geraete Gmbh | Hearing Treatment In Patients With Questionable Cochlear Nerve Functionality |
| US10292626B2 (en) * | 2011-09-21 | 2019-05-21 | Jacoti Bvba | Method and device for conducting a pure tone audiometry sceening |
| US20140236043A1 (en) * | 2011-09-21 | 2014-08-21 | Jacoti Bvba | Method and Device for Conducting a Pure Tone Audiometry Screening |
| US9550061B2 (en) | 2012-03-22 | 2017-01-24 | Advanced Bionics Ag | Programming systems for eliciting evoked responses in a cochlear implant patient and performing predetermined actions in accordance with the evoked responses |
| US9440072B2 (en) | 2012-03-22 | 2016-09-13 | Advanced Bionics Ag | Methods and systems for fitting an electro-acoustic stimulation system to a patient |
| US9776000B2 (en) | 2012-03-22 | 2017-10-03 | Advanced Bionics Ag | Programming systems for eliciting evoked responses in a cochlear implant patient and performing predetermined actions in accordance with the evoked responses |
| US9878156B2 (en) | 2012-03-22 | 2018-01-30 | Advanced Bionics Ag | Methods and systems for fitting an electro-acoustic stimulation system to a patient |
| US9486630B2 (en) | 2012-03-22 | 2016-11-08 | Advanced Bionics Ag | Electro-acoustic stimulation systems that perform predetermined actions in accordance with evoked responses |
| CN102908150A (zh) * | 2012-09-27 | 2013-02-06 | 清华大学 | 一种复合神经动作电位调谐曲线校准及检测系统 |
| CN112891742A (zh) * | 2015-01-09 | 2021-06-04 | Med-El电气医疗器械有限公司 | 经由传出神经纤维的耳蜗植入器适配 |
| US11090485B2 (en) | 2015-10-13 | 2021-08-17 | Advanced Bionics Ag | Systems and methods for intra-surgical monitoring of evoked responses that occur during an electrode lead insertion procedure |
| CN108601937A (zh) * | 2016-01-27 | 2018-09-28 | 领先仿生公司 | 在电极导线插入过程期间对耳蜗创伤的术中监测的系统和方法 |
| US11980755B2 (en) | 2016-01-27 | 2024-05-14 | Advanced Bionics Ag | Systems and methods for intra-surgical monitoring of cochlear trauma during an electrode lead insertion procedure |
| US11318298B2 (en) * | 2016-01-27 | 2022-05-03 | Advanced Bionics Ag | Systems and methods for intra-surgical monitoring of cochlear trauma during an electrode lead insertion procedure |
| WO2018037312A1 (fr) * | 2016-08-24 | 2018-03-01 | Cochlear Limited | Surveillance de l'insertion d'un ensemble de stimulation |
| US11305109B2 (en) | 2016-08-24 | 2022-04-19 | Cochlear Limited | Monitoring stimulating assembly insertion |
| US10500392B2 (en) | 2016-08-24 | 2019-12-10 | Cochlear Limited | Monitoring stimulating assembly insertion |
| US12318606B2 (en) | 2016-08-24 | 2025-06-03 | Cochlear Limited | Monitoring stimulating assembly insertion |
| JP2018153532A (ja) * | 2017-03-21 | 2018-10-04 | カシオ計算機株式会社 | 脳波測定装置、脳波測定方法及び脳波測定プログラム |
| US20200238002A1 (en) * | 2017-10-12 | 2020-07-30 | Cochlear Limited | Clinical-based automated delivery of treatment substances to the inner ear |
| US12070575B2 (en) * | 2017-10-12 | 2024-08-27 | Cochlear Limited | Clinical-based automated delivery of treatment substances to the inner ear |
| US20210138236A1 (en) * | 2019-11-07 | 2021-05-13 | Oticon Medical A/S | Method for detecting a plurality of health conditions of a cochlea |
| CN114748037A (zh) * | 2022-03-14 | 2022-07-15 | 江勇 | 一种人工植入肝脏弹性检测装置 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2076174A4 (fr) | 2012-10-24 |
| US20140094712A1 (en) | 2014-04-03 |
| US9072468B2 (en) | 2015-07-07 |
| WO2008048383A1 (fr) | 2008-04-24 |
| US9380962B2 (en) | 2016-07-05 |
| CA2673126A1 (fr) | 2008-04-24 |
| US20150289787A1 (en) | 2015-10-15 |
| AU2007313412A2 (en) | 2009-07-02 |
| AU2007313412A1 (en) | 2008-04-24 |
| EP2076174A1 (fr) | 2009-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9380962B2 (en) | Apparatus and methods for acoustically or mechanically stimulating a cochlea and intracochlear recording of mechanically or acoustically evoked auditory potentials in the cochlea | |
| US20220184384A1 (en) | Monitoring stimulating assembly insertion | |
| AU2017223495B2 (en) | Detection of electrically evoked stapedius reflex | |
| US10357656B2 (en) | Hearing prosthesis programming | |
| US20230285748A1 (en) | Electrical techniques for biomarker detection in a cochlea | |
| CN104736096B (zh) | 使用镫骨反射测量在耳蜗植入手术期间监测听力保留 | |
| US12324915B2 (en) | Inner ear electrode implantation outcome assessment | |
| Bierer et al. | Auditory outcomes following implantation and electrical stimulation of the semicircular canals | |
| Adel et al. | Band-limited chirp-evoked compound action potential in guinea pig: comprehensive neural measure for cochlear implantation monitoring | |
| US8862220B2 (en) | Artifact cancellation in hybrid audio prostheses | |
| AU2022210719B2 (en) | Optimized acoustic chirp based on in-vivo bm-delays in human | |
| AU2022210720B2 (en) | Estimation of audiogram based on in-vivo acoustic chirp | |
| Campbell | Changes in Electrocochleography to Identify Intra-Operative Trauma | |
| US20160325095A1 (en) | Novel Recording Approach of Stapedius Muscle Activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, NORTH Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BUCHMAN, CRAIG A.;ADUNKA, OLIVER F.;REEL/FRAME:022903/0704 Effective date: 20090514 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |